 <h1>Amaryl Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>glimepiride</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about glimepiride. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Amaryl.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to glimepiride: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, glimepiride (the active ingredient contained in Amaryl) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking glimepiride:</p><p>
<i>Rare</i>
</p><ul>
<li>Difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>hives</li>
<li>itching</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or  tongue</li>
<li>shortness of breath</li>
<li>skin rash</li>
<li>tightness in the chest</li>
<li>unusual tiredness or weakness</li>
<li>wheezing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>agitation</li>
<li>back, leg, or stomach pains</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>bloating of abdomen</li>
<li>blood in the urine or stools</li>
<li>bloody, black, or tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>coma</li>
<li>confusion</li>
<li>cough or hoarseness</li>
<li>dark urine</li>
<li>decreased urine output</li>
<li>depression</li>
<li>diarrhea</li>
<li>difficulty with breathing</li>
<li>fever with or without chills</li>
<li>fluid-filled skin blisters</li>
<li>general body swelling</li>
<li>general tiredness and weakness</li>
<li>headache</li>
<li>high fever</li>
<li>hostility</li>
<li>irritability</li>
<li>joint or muscle pain</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>lethargy</li>
<li>light-colored stools</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle twitching</li>
<li>nausea and vomiting</li>
<li>nosebleeds</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rapid weight gain</li>
<li>red, irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>seizures</li>
<li>sensitivity to the sun</li>
<li>skin thinness</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stupor</li>
<li>swelling of face, ankles, or hands</li>
<li>swollen or painful glands</li>
<li>unusual bleeding or bruising</li>
<li>upper right abdominal or stomach pain</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking glimepiride:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Anxiety</li>
<li>blurred vision</li>
<li>cold sweats</li>
<li>cool, pale skin</li>
<li>increased hunger</li>
<li>nightmares</li>
<li>shakiness</li>
<li>slurred speech</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of glimepiride may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Lack or loss of strength</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Redness or other discoloration of the skin</li>
<li>severe sunburn</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glimepiride: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse events included hypoglycemia, headache, nausea, asthenia, and dizziness.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypoglycemia (up to 19.7%) </p>
<p><b>Frequency not reported</b>: Weight gain</p>
<p><b>Postmarketing reports</b>: Hyponatremia, SIADH<sup>[Ref]</sup></p><p>Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH) occurred in mostly in patients who were on other medications or who had medical conditions known to cause hyponatremia or increased release of antidiuretic hormone.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, leukopenia, agranulocytosis, granulocytopenia, erythropenia, aplastic anemia, pancytopenia </p>
<p><b>Postmarketing reports</b>: Hemolytic anemia in patients without G6PD deficiency, thrombocytopenia purpura<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions such as pruritus, erythema, urticaria, a morbilliform or maculopapular eruptions </p>
<p><b>Frequency not reported</b>: Cutaneous eruptions with or without pruritus, cross-allergenicity with sulfonylureas, sulfonamides, or related substances </p>
<p><b>Postmarketing reports</b>: Anaphylaxis, angioedema, Stevens-Johnson syndrome, dyspnea<sup>[Ref]</sup></p><h3>Ocular</h3><p>Temporary visual impairment due to changes in blood glucose levels may occur due to temporary alteration in the turgidity and hence the refractive index of the lens which is dependent on blood glucose levels.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Transient visual disturbances<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects have included pruritus, erythema, urticaria, and morbilliform or maculopapular rashes in less than 1% of cases.  Sulfonylureas have caused porphyria cutanea tarda and photosensitivity reactions.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Rare</b> (less than 0.1%): Nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain, sensations of pressure or fullness in the epigastrium<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Elevated ALT</p>
<p><b>Very rare</b> (less than 0.01%): Hepatic function abnormal, hepatitis, hepatic failure</p>
<p><b>Postmarketing reports</b>: Hepatitis and liver impairment, e.g.  with cholestasis and jaundice, hepatic porphyria reactions and disulfiram-like reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Flu syndrome</p>
<p><b>Very rare</b> (less than 0.01%): Leukocytoclastic vasculitis<sup>[Ref]</sup></p><h3>Other</h3><p>Accidental injury was reported more frequently in patients receiving this drug (5.4% vs 3.4%).  There was insufficient information available to determine if these events were associated with hypoglycemia.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Asthenia, accidental injury<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Amaryl (glimepiride)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Amaryl (glimepiride)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: sulfonylureas</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Amaryl &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Diabetes, Type 2</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glimepiride: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse events included hypoglycemia, headache, nausea, asthenia, and dizziness.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hypoglycemia (up to 19.7%) </p><p><b>Frequency not reported</b>: Weight gain</p><p><b>Postmarketing reports</b>: Hyponatremia, SIADH<sup>[Ref]</sup></p><p>Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH) occurred in mostly in patients who were on other medications or who had medical conditions known to cause hyponatremia or increased release of antidiuretic hormone.<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Thrombocytopenia, leukopenia, agranulocytosis, granulocytopenia, erythropenia, aplastic anemia, pancytopenia </p><p><b>Postmarketing reports</b>: Hemolytic anemia in patients without G6PD deficiency, thrombocytopenia purpura<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions such as pruritus, erythema, urticaria, a morbilliform or maculopapular eruptions </p><p><b>Frequency not reported</b>: Cutaneous eruptions with or without pruritus, cross-allergenicity with sulfonylureas, sulfonamides, or related substances </p><p><b>Postmarketing reports</b>: Anaphylaxis, angioedema, Stevens-Johnson syndrome, dyspnea<sup>[Ref]</sup></p><h3>Ocular</h3><p>Temporary visual impairment due to changes in blood glucose levels may occur due to temporary alteration in the turgidity and hence the refractive index of the lens which is dependent on blood glucose levels.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Transient visual disturbances<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Dermatologic side effects have included pruritus, erythema, urticaria, and morbilliform or maculopapular rashes in less than 1% of cases.  Sulfonylureas have caused porphyria cutanea tarda and photosensitivity reactions.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Rare</b> (less than 0.1%): Nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain, sensations of pressure or fullness in the epigastrium<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Elevated ALT</p><p><b>Very rare</b> (less than 0.01%): Hepatic function abnormal, hepatitis, hepatic failure</p><p><b>Postmarketing reports</b>: Hepatitis and liver impairment, e.g.  with cholestasis and jaundice, hepatic porphyria reactions and disulfiram-like reactions<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Flu syndrome</p><p><b>Very rare</b> (less than 0.01%): Leukocytoclastic vasculitis<sup>[Ref]</sup></p><h3>Other</h3><p>Accidental injury was reported more frequently in patients receiving this drug (5.4% vs 3.4%).  There was insufficient information available to determine if these events were associated with hypoglycemia.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Asthenia, accidental injury<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Amaryl (glimepiride)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><h2>More about Amaryl (glimepiride)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>19 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: sulfonylureas</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Amaryl &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diabetes, Type 2</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>